Skip to main content
. 2019 Feb 22;54(4):1168–1182. doi: 10.3892/ijo.2019.4723

Table II.

Distribution of primary tumor sites in patients with somatic TP53 mutations.

p53 mutation Colon, n Lung, n Breast, n Ovary, n Brain, n Esophagus, n Bladder, n Other, n P-valuea Q
NULL 548 686 749 596 221 464 242 2333 - -
MIS 2326 2307 2304 1632 1542 1423 1159 9114 < 0.0001 0.0001
R248Q 159 37 113 54 75 49 53 415 < 0.0001 0.0001
R248W 147 47 84 58 57 60 25 292 < 0.0001 0.0001
R175H 290 37 131 107 107 99 38 412 < 0.0001 0.0001
R273H 165 54 98 94 80 47 21 304 < 0.0001 0.0001
a

Versus NULL group. p53, tumor suppressor p53; MIS, any missense mutation.